Ameriprise’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.43M | Sell |
250,149
-19,029
| -7% | -$413K | ﹤0.01% | 2287 |
|
|
2025
Q1 | $6.53M | Sell |
269,178
-13,656
| -5% | -$331K | ﹤0.01% | 2097 |
|
|
2024
Q4 | $5.9M | Buy |
282,834
+5,177
| +2% | +$108K | ﹤0.01% | 2242 |
|
|
2024
Q3 | $5.52M | Sell |
277,657
-39,318
| -12% | -$782K | ﹤0.01% | 2302 |
|
|
2024
Q2 | $4.91M | Sell |
316,975
-64,375
| -17% | -$997K | ﹤0.01% | 2329 |
|
|
2024
Q1 | $6.08M | Sell |
381,350
-70,885
| -16% | -$1.13M | ﹤0.01% | 2213 |
|
|
2023
Q4 | $7.6M | Buy |
452,235
+35,476
| +9% | +$596K | ﹤0.01% | 2017 |
|
|
2023
Q3 | $4.87M | Sell |
416,759
-20,209
| -5% | -$236K | ﹤0.01% | 2311 |
|
|
2023
Q2 | $5.87M | Sell |
436,968
-18,271
| -4% | -$246K | ﹤0.01% | 2219 |
|
|
2023
Q1 | $7.55M | Sell |
455,239
-181,502
| -29% | -$3.01M | ﹤0.01% | 1998 |
|
|
2022
Q4 | $11.8M | Buy |
636,741
+14,386
| +2% | +$268K | ﹤0.01% | 1605 |
|
|
2022
Q3 | $7.99M | Buy |
622,355
+414,034
| +199% | +$5.31M | ﹤0.01% | 1870 |
|
|
2022
Q2 | $1.46M | Buy |
208,321
+11,241
| +6% | +$78.8K | ﹤0.01% | 2950 |
|
|
2022
Q1 | $1.63M | Sell |
197,080
-341,779
| -63% | -$2.83M | ﹤0.01% | 3001 |
|
|
2021
Q4 | $3.65M | Buy |
538,859
+477,832
| +783% | +$3.23M | ﹤0.01% | 2678 |
|
|
2021
Q3 | $324K | Buy |
+61,027
| New | +$324K | ﹤0.01% | 3534 |
|
|
2021
Q2 | – | Sell |
-10,955
| Closed | -$50K | – | 3897 |
|
|
2021
Q1 | $50K | Hold |
10,955
| – | – | ﹤0.01% | 3797 |
|
|
2020
Q4 | $37K | Sell |
10,955
-17,911
| -62% | -$60.5K | ﹤0.01% | 3727 |
|
|
2020
Q3 | $86K | Buy |
28,866
+2,074
| +8% | +$6.18K | ﹤0.01% | 3649 |
|
|
2020
Q2 | $124K | Buy |
+26,792
| New | +$124K | ﹤0.01% | 3562 |
|
|
2018
Q1 | – | Sell |
-341,956
| Closed | -$1.34M | – | 3625 |
|
|
2017
Q4 | $1.34M | Buy |
+341,956
| New | +$1.34M | ﹤0.01% | 2848 |
|